PDA Ready-to-Use Primary Drug Container Solutions Workshop 2026
Become a Sponsor and/or Exhibitor
Registration Options
Individual Registration
Group Registration
The PDA Ready-to-Use Primary Drug Container Solutions Workshop 2026, will be held in Munich, Germany, on 13 April 2026, prior to The PDA Parenteral Packaging Conference 2026, provides a deeper view on this scope and is an opportunity to examine the topic from three critical perspectives: the Primary Packaging Provider, the Machine Manufacturer, and the Fill & Finish/User. Each perspective highlights unique challenges, requirements, and opportunities within the primary drug container value chain.
Participants can expect an interactive workshop format, including group work to explore real-world scenarios, share insights, and develop solutions collaboratively. Outcomes from these exercises will be presented and discussed, providing actionable take-home messages and a broader understanding of cross-functional perspectives.
The agenda preview is out!
Highlighted Presenters
Key Presenters
Agenda
Discover What's Happening Each Day
(Note: The file may take a moment to download depending on your connection.)
CEST Daylight Time (UTC +2:00)
-
General Introduction and Overview of the Scope
This interactive session will provide a practical, case-based approach to evaluating the implementation of ready-to-use vials versus bulk vials. Participants will work through a realistic case to assess technical, operational, and economic factors influencing the decision to switch to RTU vials or continue with bulk processes. Moreover, participants will develop an implementation strategy to support the transition from bulk vials to RTU vials that addresses technical feasibility, regulatory pathway, sterility assurance, validation scope, equipment compatibility, cleanroom and automation changes, timeline, cost considerations, and risk mitigation.
-
-
Perspective From a Primary Packaging Provider
Unlocking RTU Potential: Collaborative Pathways to navigate Implementation Challenges
From the perspective of primary packaging providers within the RTU Alliance, the increasing adoption of RTU containers reflects a clear shift toward greater flexibility and efficiency in the development of injectable drug products. As manufacturers seek faster time-to-market and more streamlined aseptic processing, RTU formats are becoming a key enabler. Primary packaging suppliers support this shift by offering pre-validated, contamination-controlled solutions that facilitate scalable and reliable manufacturing. Looking ahead, successful implementation will require addressing remaining challenges such as supply-chain integration, regulatory alignment, and compatibility across formats. A phased, low-risk approach will be essential to ensure smooth adoption and to fully leverage the advantages that RTU systems can bring to future manufacturing strategies.
-
-
Perspective From Machine Manufacturers
Comparing Bulk and RTU Fill & Finish Processes: A Machine Manufacturer’s Perspective
Highlighting Key Differences between Technologies
This presentation provides one possible impression of existing processes of how Bulk and Ready-to-Use (RTU) processes compare within Fill & Finish manufacturing, viewed from the perspective of equipment manufacturers. It highlights key differences between the two approaches, examines their influence on machine design and process workflows, and discusses associated challenges. The goal is to offer a representative, but not exhaustive, perspective on how these technologies diverge and what this means for manufacturing operations.
-
-
Perspective from Fill & Finish User
From Bulk to Ready to Use: Evaluating RTU Vial Implementation for Pharmaceutical Companies
As industry discussions about RTU vial integration continue to evolve, this presentation aims to support pharmaceutical leaders in evaluating practical implementation approaches, anticipating future developments, and optimizing sterile manufacturing efficiency. While RTU cartridges and prefilled syringes (PFS) are widely regarded as the gold standard and broadly adopted across the industry, the transition from traditional “bulk” vials to RTU vials remains a topic of active debate. This presentation focuses on RTU vials and examines the advantages and challenges of their implementation from the perspective of pharmaceutical companies. Key considerations include cost structures, equipment compatibility, sterility assurance strategies, cleanroom configurations, levels of automation, and the scope of validation required to integrate RTU vials into established manufacturing lines originally designed and qualified for handling and filling “bulk” vials.
-
-
Networking Coffee Break
-
Interactive Session Part I
-
Networking Lunch Break
-
Interactive Session Part II
-
Networking Coffee Break
-
Continue Interactive Session Part II
-
Group Discussion and Outcome
-
Summary of the Workshop and Take-Home Messages
Finally, participants will gain clear learning points and take-home messages to support informed decision-making on RTU vial implementation.
-
-
End of Workshop and Farewell
Program Planning Committee
The Team Behind the Event's Agenda
Location and Travel
Venue Details and Accommodations
PLEASE READ PDA is not affiliated or contracted with any outside hotel contracting company. If someone other than PDA or the PDA chosen hotel contacts you suggesting that they represent any PDA event, they do not. It is PDA's recommendation that you book your hotel directly through the official PDA chosen hotel that is listed on our web site.
Munich Marriott Hotel City West
Landsberger Strasse 156Munich, Germany 80687 Germany
PDA recommends the reservation at the following hotel
Munich Marriott Hotel City West
Landsberger Strasse 156
80687 Munich
Germany
PDA Europe has reserved a limited number of rooms until 12 March 2026.
Book your room at the PDA Group Rate using the above-mentioned reservation button.
Registration
Pricing Options
Standard Registration
Member Price
€ 1,100Non-Member
€ 1,200
ALL PRICES IN EURO (EUR), EXCLUDING VAT.
WAYS TO REGISTER: 1. Online Registration 2. registration-europe@pda.org
PDA MEMBERS: Please remember to log in before registering If you come from a Governmental or Health Authority Institution or from an Academic Organization, please contact registration-europe@pda.org before registering.
If you need to apply for a visa to enter the event country, PDA Europe must be informed of this fact at least 4 weeks before the start of the event.
Presenters
PDA events bring together top-notch industry experts, innovators, and practitioners who are shaping the future of pharmaceutical science and manufacturing. Our presenters are selected for their experience, insight, and commitment to elevating the global community through knowledge sharing.
Sponsor information will be available soon
We're currently finalizing our list of sponsors and will share the details shortly.
Become a Sponsor and/or Exhibitor
Amplify Your Presence and Reach Your Customers!
Become a Sponsor
Elevate your brand and maximize your exposure by becoming a sponsor at the PDA Ready-to-Use Primary Drug Container Solutions Workshop 2026! Connect with industry leaders, showcase your products and services, and establish your company as a key player in the field.
Request InformationBecome an Exhibitor
Boost your brand and visibility by becoming an exhibitor at the PDA Ready-to-Use Primary Drug Container Solutions Workshop 2026! Connect with industry influencers, showcase your products and services, and position your company as a key player in the field.
Request InformationRelated Workshop and Conference
-
Co-Chairs:
Coralie Richard PhD
Eli Lilly and Company
Bram Jongen PhD
Datwyler
Have a question or need assistance?
Send us a message, and our team will get back to you shortly. We're here to help!